Resource

 

 

 

 

 

 

 

 

 

 

 

Banking & Finance - Capital Markets: Equity

Pinsent Masons advises Numis on £75 million Cambridge Innovation Capital fundraising

22 Aug 2016

International law firm Pinsent Masons has advised Numis on a £75 million fundraising for University of Cambridge investor, Cambridge Innovation Capital (CIC).

The funds will be used to provide investment to CIC's portfolio of technology businesses developed by the University of Cambridge and the wider Cambridge cluster, Europe's largest technology hub.

CIC launched in 2013 to provide growth capital to local tech businesses providing long term capital to support the sustained growth of investee companies.

Eversheds advises NewRiver on its transfer from AIM to Premium Listing segment of the Official List

19 Aug 2016

Eversheds has advised NewRiver REIT plc on the admission of its shares to the premium listing segment of the Official List of the UK Listing Authority and the simultaneous cancellation of the shares of NewRiver Retail Limited on AIM. Admission of NewRiver REIT’s shares to trading on the London Stock Exchange’s Main Market took effect on 18 August at 8.00am.

Clifford Chance advises on China Everbright Securities' US$1.12 billion IPO

18 Aug 2016

Leading international law firm Clifford Chance has advised the underwriters, including Everbright Securities, UBS and Merrill Lynch, on China Everbright Securities' US$1.12 billion listing on the Hong Kong Stock Exchange. China Everbright Securities is one of the largest securities brokerage by assets in China and is controlled by state-owned financial conglomerate, China Everbright Group.

Clifford Chance advises on China Everbright Securities' US$1.03 billion IPO

18 Aug 2016

Leading international law firm Clifford Chance has advised the underwriters, including Everbright Securities, UBS and Merrill Lynch, on China Everbright Securities' US$1.03 billion listing on the Hong Kong Stock Exchange. China Everbright Securities is one of the largest securities brokerage by assets in China and is controlled by state-owned financial conglomerate, China Everbright Group.

Taylor Wessing advises Verona Pharma on a placing to raise £44.7million

17 Aug 2016

International law firm Taylor Wessing has advised its longstanding biotech client Verona Pharma plc on a UK and US placing/pipe investment to raise gross proceeds of £44.7m (US$63.3m). The cornerstone investors in the placing were specialist healthcare focused funds Vivo Capital, OrbiMed and Edmond de Rothschild Investment Partners.

Cadwalader Advises on Indian IPO and Global Offering for Dilip Buildcon Limited

15 Aug 2016

Cadwalader successfully acted as international counsel in relation to Dilip Buildcon Limited’s US$100 million initial public offering of shares listed on the National Stock Exchange and Bombay Stock Exchange of India. Book running lead managers were Axis Capital Limited, IIFL Holdings Limited, JM Financial Institutional Securities Limited and PNB Investment Services Limited. The listing and commencement of trading occurred on 11 August 2016.

Travers Smith advises Benchmark Holdings plc on its placing to raise £30.7 million

11 Aug 2016

Travers Smith corporate partner Adrian West, senior corporate assistant Jamie Lumsden and corporate assistant Isabel Dwan have advised Benchmark Holdings plc, the international biotechnology and food chain sustainability business, in connection with its placing of 47,279,127  new ordinary shares at a price of 65 pence per share to raise approximately £30.7 million before expenses.

The proceeds of the placing are intended to be used by the company to invest in certain strategic joint ventures and capital projects.